Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Gross Profit (2016 - 2025)

Historic Gross Profit for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $24.5 million.

  • Sanara MedTech's Gross Profit rose 2428.91% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.0 million, marking a year-over-year increase of 3357.65%. This contributed to the annual value of $78.5 million for FY2024, which is 3744.56% up from last year.
  • Per Sanara MedTech's latest filing, its Gross Profit stood at $24.5 million for Q3 2025, which was up 2428.91% from $23.9 million recorded in Q2 2025.
  • Sanara MedTech's Gross Profit's 5-year high stood at $24.5 million during Q3 2025, with a 5-year trough of $4.5 million in Q1 2021.
  • Moreover, its 5-year median value for Gross Profit was $13.6 million (2023), whereas its average is $14.0 million.
  • Per our database at Business Quant, Sanara MedTech's Gross Profit surged by 11923.66% in 2021 and then soared by 2281.97% in 2023.
  • Quarter analysis of 5 years shows Sanara MedTech's Gross Profit stood at $6.3 million in 2021, then soared by 107.13% to $12.9 million in 2022, then increased by 22.82% to $15.9 million in 2023, then soared by 51.28% to $24.1 million in 2024, then increased by 1.68% to $24.5 million in 2025.
  • Its last three reported values are $24.5 million in Q3 2025, $23.9 million for Q2 2025, and $21.6 million during Q1 2025.